Potentiation of pharmaceuticals
Patent 6066643 Issued on May 23, 2000. Estimated Expiration Date: 
October 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPharmaceutical products of moxonidine and hydrochlorothiazide Potentiation of drug response Method of inhibiting hyperglycemia and pharmaceutical composition for use therein Patent #: 5712283 InventorAssigneeApplicationNo. 169369 filed on 10/09/1998US Classes:514/269, Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety514/317, Additional ring containing514/651Ether oxygen is part of the chainExaminersPrimary: Henley, III, RaymondAttorney, Agent or FirmInternational ClassesA61K 031/505A61K 031/445 A61K 031/135 AbstractThe present invention provides a method for producing a potentiating effect on a therapeutic action of an agent which is selected from a serotonin re-uptake inhibitor, a norepinephrine re-uptake inhibitors, both a serotonin and norepinephrine re-uptake inhibitor, and an atypical antidepressant in a warm blooded mammal, which comprises administering to said mammal an effective amount of moxonidine, or a pharmaceutically acceptable salt thereof.Other References
| |
